The Cancer Letter

Inside information on cancer research and drug development

Vol.
18
No.
28
July 10, 1992Jul 10, 1992
Free
DOWNLOAD THE PDF

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

More DCT Concepts Approved By Advisors

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

Procedures For Ending IGs Announced

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account